The occurrence of thrombocytopenia in 5% of pregnant women at delivery, described as gestational thrombocytopenia, is well documented. A commonly believed concept is that gestational thrombocytopenia is the result of gradually decreasing platelet counts in all women during pregnancy. The goal of our study was to evaluate the data supporting this concept. To learn what is known about platelet counts throughout normal pregnancies, we systematically reviewed all publications describing platelet counts during pregnancy. We identified 3,039 studies; 46 reporting 30 women with normal pregnancies were included in our analyses. The combined mean platelet counts from all studies supported the concept that platelet counts decrease during pregnancy and increase postpartum: first trimester, 251,000/mL (95% CI, 238,000-264,000/mL); second trimester, 238,000/mL (95% CI, 222,000-253,000/mL); third trimester, 224,000/mL (95% CI, 213,000-235,000/mL); delivery, 237,000/mL (95% CI, 209,000-264,000/mL); 4-8 weeks postpartum, 247,000/mL (95% CI, 207,000-287,000/mL). However, individual studies were inconsistent. Eleven longitudinal studies compared platelet counts on the same women at different times during gestation: seven reported a decrease; four reported no change. Ten cross-sectional studies compared platelet counts of different women at different times during gestation: five reported a decrease; five reported no change. Five studies compared platelet counts of pregnant to nonpregnant women: three reported that platelet counts were lower in pregnant women; one reported no difference; one reported that platelet counts were higher in pregnant women. These inconsistent data emphasize the need to accurately describe platelet counts throughout normal pregnancies.
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Accurate data are essential for evaluating the clinical importance of thrombocytopenia during pregnancy.
| I N TR ODU C TI ON
Mild thrombocytopenia in pregnant women at the time of delivery, described as gestational thrombocytopenia, has been well documented in three large studies during that past 24 years (Table 1) . [1] [2] [3] The reduced, but symmetrical, distribution of platelet counts at delivery suggests that a shift from normal values to lower platelet counts occurs in all women. [2] [3] [4] [5] These observations have led to the common belief that a physiologic change associated with pregnancy causes platelet counts to gradually decrease. Since we were not familiar with data documenting the course of platelet counts throughout normal pregnancies, we performed a systematic review of published reports of platelet counts during pregnancy, at delivery, and postpartum to address this question: "Do published data document that platelet counts of all women decrease during the course of normal pregnancies?" Documenting the course of platelet counts throughout normal pregnancies is not only important for understanding the mechanism of gestational thrombocytopenia; it is also essential for the accurate evaluation of incidentally discovered thrombocytopenia in pregnant women. Low platelet counts at delivery, which are typically mild but may be as low as 43,000/mL, 6,7 are well described, occurring in 5% of women without other disorders or complications of pregnancy. 1 However the time during pregnancy when thrombocytopenia occurs is not clearly described. 7, 8 Therefore the goal of our systematic review was to document what is known about platelet counts throughout the course of normal pregnancies and postpartum.
| M E TH ODS

| Study identification
We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 9 to design and report the methods and results of our systematic review. JAR searched eight databases using different interfaces to identify studies evaluating mean platelet counts during normal pregnancies, published from the inception of the database through June 2015. Additional studies were identified from the bibliographies of reviewed studies. Searches were limited to human subjects and English language. Published abstracts were included if they contained primary data that had not been published in a complete study.
The complete search strategy and the results of the searches are presented in Supporting Information Table S1 .
| Study selection
Inclusion and exclusion criteria were established a priori by both JAR and JNG. We had two inclusion criteria. The study needed to report of primary data on platelet counts in 30 women for at least one time point during pregnancy. If studies reported platelet counts at multiple times during pregnancy, only data from 30 women were included in our analysis. Also studies needed to describe the women as having normal pregnancies. If women with normal pregnancies were not distinguished from women with complications of pregnancy or other disorders, the article was not included. If the authors reported specific criteria to document that pregnancies were normal, these criteria were recorded. If no criteria were reported, the authors' description of pregnancies as normal was accepted. We excluded studies that did not report the mean platelet count and standard deviation, or sufficient data to calculate the mean platelet count and standard deviation; studies that did not report the gestational age when the platelet counts were determined; and studies in which women were selected based on their platelet count (e.g., thrombocytopenic women) or because of a complication of pregnancy.
Each title and/or abstract was reviewed by JAR to determine if the study potentially met our criteria. When the selection criteria were present, or not clearly apparent from the title or abstract, the study was retrieved for full-text review. Full-text review was performed by JAR and JNG.
| Data extraction
For studies meeting our selection criteria after full-text review, we recorded the authors, citation, study design, country of the participants, selection of participants, definition of normal pregnancy, gestational age when platelet counts were measured, number of women for each platelet count measurement, mean platelet count and standard deviation.
| Assessment of risk of bias
To assess the risk of bias among the selected studies, we determined the quality of each study's methodology. We defined studies as higher quality if they met the two of the eight criteria of the NewcastleOttawa Quality Assessment that are applicable to studies without a comparison group. 10 These criteria are adequate case definition (whether the study reported specific inclusion and/or exclusion criteria for identifying women with a normal pregnancy) and representative cases (whether consecutive patients were enrolled in the study).
| Calculation of mean platelet counts from multiple studies
The time during pregnancy when platelet counts were reported was described as 1st trimester 0-13 weeks, 2nd trimester 14-27 weeks, we excluded 188 studies. Therefore we included 46 studies in our analysis (Figure 1 ). There were no abstracts among the 46 included studies. The three large, landmark studies of platelet counts at delivery were excluded from our review because they only reported platelet counts as >150,000/mL or 150,000/mL 1 or they did not report platelet counts separately for women with normal pregnancies and women with complications 2, 3 ( Table 1) . The combined mean platelet counts with 95% confidence intervals (CI) during each trimester, at delivery and at 4-8 weeks postpartum from all 46 studies are presented. When studies reported multiple platelet counts during pregnancy, the first platelet count within each trimester was selected. Supplement Table 2 describes when during pregnancy that platelet counts were obtained for each of the 46 studies. Data from each individual study are presented in Supporting Information Figure S1 , with Forest plots to display the mean values of each individual study and the combined mean values for each trimester, at delivery, and postpartum. ) reported platelet counts for all three trimesters and postpartum. Two longitudinal studies 15, 22 reported platelet counts only at delivery and postpartum. Ten (22%) of the 46 studies were described as higher quality because they reported both specific inclusion and/or exclusion criteria for identifying women with a normal pregnancy and enrolled consecutive patients. 4, 17, 19, 20, 22, 24, 26, 38, 51, 55 None of the studies reported platelet counts related to maternal age or by race/ethnicity groups. The study design, country, purpose of the study, and platelet counts reported for each of the 46 studies are presented in Supporting Information Table S2. 3.3 | Combined mean platelet counts during pregnancy and postpartum from all 46 studies Table 2 presents the combined mean platelet counts and 95% confidence intervals for each trimester, at delivery, and postpartum.. 3.5 | Individual studies comparing platelet counts of pregnant to nonpregnant women Table 5 presents the data for the five studies that compared platelet counts of pregnant women to a control group of nonpregnant women.
FIG URE 1 Results of the literature search
| Individual studies comparing platelet counts during gestation and postpartum
One additional study reported platelet counts on nonpregnant women but did not compare them to the platelet counts of pregnant women. 14 Three of the studies in Table 5 reported that platelet counts of pregnant women were significantly lower than the platelet counts of nonpregnant women and one reported no difference. One study reported that platelet counts of nonpregnant women were significantly higher than platelet counts of pregnant women. Data from all 15 longitudinal studies are presented. When platelets counts were measured at more than one time during pregnancy, only the earliest and latest platelet counts are presented in this Table. All platelet counts that were reported at delivery and postpartum are presented in this Table. Two of the 15 studies (Dundar, Yang) did not compare platelet counts obtained at different times during gestation; therefore only their point estimates are presented. The comparisons involved the data presented in this Table except for Fenton, who measured platelet counts at eight times during pregnancy; comparison among all eight platelet counts by analysis of variance reported no significant difference. Singer, Fallahian, and Heilmann only reported that there was no significant difference between platelet counts at different times during pregnancy, without reporting a P-value. Haliloglu and Karlsson analyzed both the platelet count decrease during pregnancy and increase from the last pregnancy measurement to the postpartum measurement. Both were significantly different. *Studies with higher quality methodology, as defined in Methods. pp, postpartum.
| D I SCUSSION
The occurrence of mild thrombocytopenia at delivery in women with normal pregnancies is well established. [1] [2] [3] 7, 8 The symmetrical distribution of platelet counts at delivery has led to the common belief that physiologic changes of pregnancy cause lower platelet counts in all women, resulting in some women with platelet counts that fall below the lower limit of normal. 2, 3, 5 However, actual documentation of platelet counts throughout the course of normal pregnancies, preceding delivery, is inconsistent. All reported data from these 10 studies are reported. Harrison and Choi only reported that there was no significant difference between platelet counts at different times during pregnancy and postpartum, without reporting a P-value. *Study with higher quality methodology, as defined in Methods. pp, postpartum. Although there are suggestions of support for the concept that platelet counts of all women gradually decrease during pregnancy, the important conclusions of our review are that we identified only 46 studies that reported platelet counts in 30 women during normal pregnancies, and that only 23 of these studies compared platelet counts at different times during pregnancy, and that the results of these comparisons were inconsistent. These data emphasize the need for additional studies to accurately describe the course of platelet All data from five studies that compared platelet counts between pregnant and non-pregnant women. *Study with higher quality methodology, as defined in Methods.
counts throughout normal pregnancies, to document when during gestation that platelet counts begin to decrease, and to determine the range of platelet counts among normal women during pregnancy.
These data are clinically important. Although platelet counts as low as 43 ,000/mL 6,7 may be rare, the range of platelet counts that are consistent with the diagnosis of gestational thrombocytopenia at each trimester and at delivery must be established. Physicians must be able to distinguish the physiologic thrombocytopenia of normal pregnancies from pathologic conditions that require additional evaluation and management. 
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